Blood test kit
Latest Critical Care Diagnostics, Inc. Patents:
Description
The features shown in broken lines in the drawings depict environmental subject matter only and form no part of the claimed design.
Claims
The ornamental design for a blood test kit, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
5728587 | March 17, 1998 | Kang |
5939331 | August 17, 1999 | Burd |
6239445 | May 29, 2001 | Shaeef |
6267722 | July 31, 2001 | Anderson |
D454398 | March 12, 2002 | Robertson |
D456082 | April 23, 2002 | Bouse |
D467348 | December 17, 2002 | McMichael |
D468437 | January 7, 2003 | McMenamy |
D495805 | September 7, 2004 | Lea |
D500142 | December 21, 2004 | Crisanti |
6855561 | February 15, 2005 | Jerome |
D512512 | December 6, 2005 | Bell |
D531321 | October 31, 2006 | Godfrey |
7285425 | October 23, 2007 | Shareef |
D561344 | February 5, 2008 | Kozak |
7326578 | February 5, 2008 | Bateman |
D602599 | October 20, 2009 | Xiaowei |
7847946 | December 7, 2010 | Krauth |
D639977 | June 14, 2011 | Francis |
D640389 | June 21, 2011 | Francis |
D655424 | March 6, 2012 | Castanon |
D660977 | May 29, 2012 | Wagner |
D660978 | May 29, 2012 | Wagner |
8268636 | September 18, 2012 | Nazareth |
D668350 | October 2, 2012 | Rowley |
D668779 | October 9, 2012 | Khan |
8278109 | October 2, 2012 | Nazareth |
D676570 | February 19, 2013 | Chance |
- Sanada, et al.,“IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System”; The Journal of Clinical Investigation; May 10, 2007.
- Sanchez-Mas, et al.; “Modulcation of IL-33/ST2 System in Postinfraction Heart Failure: correlation with Cardiac Remodeling Markers”; European Journal of Clinical Investigation; vol. 44; 2014; pp. 643-651.
- Seki, et al., “Interleukin-33 Prevents Apoptosis and Improves survival After Experimental Myocardial Infarction Through ST2 Signaling”; American Heart Association; Feb. 16, 2010.
Patent History
Patent number: D770057
Type: Grant
Filed: Sep 23, 2014
Date of Patent: Oct 25, 2016
Assignee: Critical Care Diagnostics, Inc. (San Diego, CA)
Inventors: James V. Snider (San Diego, CA), David Geliebter (Palm Beach Gardens, FL)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Mark Cavanna
Application Number: 29/503,093
Type: Grant
Filed: Sep 23, 2014
Date of Patent: Oct 25, 2016
Assignee: Critical Care Diagnostics, Inc. (San Diego, CA)
Inventors: James V. Snider (San Diego, CA), David Geliebter (Palm Beach Gardens, FL)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Mark Cavanna
Application Number: 29/503,093
Classifications
Current U.S. Class:
Interrelated Indication Or Reaction Set (i.e., "test Kit") (64) (D24/223)